GSK buys US cancer drugmaker Tesaro for hefty $5.1bn
GSK has fallen behind rivals in producing multibillion-dollar blockbusters
GSK has fallen behind rivals in producing multibillion-dollar blockbusters
Cantillon: Brexit decision may be giving Big Pharma doubts about British location
Emma Walmsley’s lack of experience cited as justification for salary
Pharma concerned that alternative to Advair will be approved in US
GSK’s Bexsero the only vaccine for now and is struggling to meet demand
Walmsley will succeed Andrew Witty when he retires
Drugmaker had argued against UK exit from EU over fears about drug regulation
Consumer profit margins rise to 17% from 12% in the previous three months as CEO says company could achieve target of 20% or more ahead of 2020 target
Swiss-Irish food group Aryzta rounds off difficult few days with modest decline
Andrew Witty tells investors he will improve profitability at Glaxo’s consumer unit
CEO Witty focuses on depth of research pipeline which features around 40 potential new drugs and vaccines
GSK to receive net after tax proceeds of $7.8 bn
Trócaire chief says there is a window of six weeks to bring crisis under control
Peter Humphrey convicted of illegally obtaining personal details of Chinese citizens
Chief executive Witty steps back from AstraZeneca battle, declairing caution on mega deals
Transactions worth $140bn so far this year include asset swap between Novartis and GlaxoSmithKline
London Briefing: major drug shares in UK soar on talk of mergers, acquisitions and asset swaps
The prediction does not take into account the negative impact of a strengthening pound
Firm also plans to stop tying compensation of sales reps to prescriptions written
China sales slump 61% as doctors shun GSK products
Crosswords & puzzles to keep you challenged and entertained
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices